J. Jimeno

In vitro schedule-dependency of myelotoxicity and cytotoxicity of Ecteinascidin 743 (ET-743).

M. Ghielmini, C. Sessa, E. Erba, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Predictive Factors of Sensitivity to Elisidepsin, a Novel Kahalalide F-Derived Marine Compound

I. Bièche, E. Raymond, C. Galmarini, 2013, Marine drugs.

Reports of Clinical Benefit of Plitidepsin (Aplidine), a New Marine-Derived Anticancer Agent, in Patients With Advanced Medullary Thyroid Carcinoma

E. Raymond, S. Faivre, J. López-Martín, 2009, American journal of clinical oncology.

New Marine Derived Anticancer Therapeutics ─ A Journey from the Sea to Clinical Trials

K. Rinehart, J. Jimeno, P. Scheuer, 2004, Marine Drugs.

Pharmaceutical development of anticancer agents derived from marine sources

J. Schellens, J. Beijnen, J. Jimeno, 2000, Anti-cancer drugs.

Pharmaceutical development of a parenteral lyophilized formulation of the novel antitumor agent aplidine.

A. Heck, J. Beijnen, H. Talsma, 2000, PDA journal of pharmaceutical science and technology.

Reports of Clinical Benefit of Plitidepsin (Aplidine), a New Marine-Derived Anticancer Agent, in Patients With Advanced Medullary Thyroid Carcinoma

E. Raymond, S. Faivre, J. López-Martín, 2009, American journal of clinical oncology.